Warby Parker Director Sold: A Deep Dive Into the Trade
Insider trades can reveal more than cash changing hands. Explore how a recent Warby Parker director sold shares, what...
Which Cash Back Card Has No Fees
Discover which cash back cards have no fees. Find your ideal card and enjoy rewards without extra costs.
28,185 articles
Here's Materials Continues to Soar: MP Materials in 2026
MP Materials is catching investor attention again in 2026 as policy support, domestic production efforts, and a risin...
Wall Street Analyst Believes Palantir Could Double in a Year
Palantir has volatile days, but one wall street analyst believes the stock could double within a year. This article b...
Apple’s Lazy Strategy Could Redefine AI Investing Landscape
Apple is taking a guarded AI route, leaning on partnerships and modest capex. The strategy could alter AI investing d...
Can Meta Platforms Become Neocloud? Investor Outlook
Meta Platforms is signaling a bold pivot toward AI-focused cloud capacity. This article breaks down what neocloud wou...
IGV Bounces 5% as SaaS Selloff May Still Be Over
IGV climbed roughly 5% over the past week, defying a broader tech pullback. Yet traders remain split on whether the A...
ITG's Sold Nearly 6,000: What It Means for Investors
When a CEO sells thousands of shares, investors want to know what it signals. This guide explains how to read insider...
Stratasys: Printing Pioneer Struggling in a Shifting Market
Stratasys has long been a trailblazer in 3D printing, but the road ahead is proving tougher amid competition and cost...
Price Prediction for This Popular Blue-Chip Dividend Stock
PepsiCo stock faces a fresh price prediction this popular blue-chip dividend stock, with an upside case built on inte...
Wells Fargo Raises Targets on UNFI as MTDR Gains Follow
Analysts boosted targets on UNFI and MTDR after solid quarterly results, signaling renewed investor optimism as pipel...
Micron Delivers Strong Earnings, Elevates Full-Year Guidance
Micron Technology reports a robust third quarter, beating expectations and raising guidance amid a fraught memory mar...
Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status